# PHASE-2A — Data-Only Multi-Insurer Batch Certification Checkpoint

**Status:** CERTIFIED CHECKPOINT  
**Date:** 2026-08-15  
**Parent gate:** `PHASE_2A_DATA_ONLY_HEALTH_ONBOARDING_AND_REVIEW_SCALING_GATE.md` remains **ACTIVE**.

## Scope of this certification

This checkpoint certifies the first Phase-2A multi-insurer Health onboarding batch as complete for the governed artifact set audited by `phase_2a_first_multi_insurer_health_batch_audit_spec.json`.

It does **not** certify the full Phase-2A exit criteria. Review-effort scaling evidence and broader regression validation remain required before the parent gate can close.

## Certified batch

1. `star_health:star_comprehensive`
2. `bajaj_allianz_general:my_health_care`
3. `aditya_birla_health:activ_one`

The batch spans three insurers and uses the generic governed onboarding path rather than dedicated product reasoning implementations.

## Final batch audit evidence

User-executed audit on 2026-08-15 reported:

```text
Products                     : 3
Products with missing data   : 0
Missing/undeclared artifacts : 0
  declared_missing           : 0
  not_declared               : 0
Review routing records       : 0
Routing N/A (no input)       : 3
Risk tiers                   : {'critical': 0, 'high': 0, 'medium': 0, 'low': 0}
Product-specific code changes: 0
```

Per product:

```text
star_health:star_comprehensive
  complete for audited artifact set
  review_routing_applicability: not_applicable_no_review_input

bajaj_allianz_general:my_health_care
  complete for audited artifact set
  review_routing_applicability: not_applicable_no_review_input

aditya_birla_health:activ_one
  complete for audited artifact set
  review_routing_applicability: not_applicable_no_review_input
```

The audit is read-only and creates no product fact, adjudication or publication decision.

## Currentness evidence outcomes

### Star Comprehensive

The official Star policy wording observed on 2026-08-15 was byte-identical to the already registered immutable source version:

```text
b1dbe8fb78646f75566d47c32b7ebfa27c4071941c8f548224c461ee35a8021f
```

The governed path then produced:

```text
source observation      : byte_identical_observed
currentness evidence    : sufficient_for_current_observed_review
positive evidence       : 1
identity resolution     : resolved
reviewed temporal state : current_observed_reviewed
evidence review         : eligible_for_evidence_review
current entitlement     : eligible
```

Eligibility remains distinct from publication.

### Bajaj My Health Care

HEALTH-EXPANSION-1 had already established a separately registered immutable current version and reviewed currentness path. The batch reuses that governed state; it does not recreate or mutate the unavailable historical source bytes.

### Aditya Birla Activ One

The historical governed policy-wording hash `d7726811...` was not retained, while the historical prospectus hash `8923d645...` was retained. The missing wording remains explicit historical provenance debt and was not reconstructed.

A newly observed official policy wording was registered as a separate immutable version:

```text
38bb879030d905bd6f90915915f1c2e22e27ebe5bc980bba766c69c7ecd90a16
```

The governed path then produced:

```text
source observation      : byte_identical_observed
currentness evidence    : sufficient_for_current_observed_review
positive evidence       : 1
identity resolution     : resolved
reviewed temporal state : current_observed_reviewed
evidence review         : eligible_for_evidence_review
current entitlement     : eligible
```

No semantic equivalence with the missing historical `d772...` version is claimed.

## MO-029 review-routing applicability

MO-029 risk routing is operational and separately certified. This batch does not yet contain reviewer-ready review-group input for the three products.

Therefore the correct state is:

```text
review_routing_applicability = not_applicable_no_review_input
```

This is not a bypass. Once reviewer-ready groups exist, review-risk routing becomes required. The audit was corrected so a downstream stage with no legitimate input is not counted as a missing onboarding artifact.

## Focused validation

User-executed validation:

```text
16 passed in 0.28s
```

covering:

- `tests/factory_core/test_health_onboarding_batch_audit.py`
- `tests/factory_core/test_review_risk_routing.py`

The source-hash locator was also previously validated:

```text
5 passed in 0.16s
```

## Standing acceptance criterion

The batch satisfies the central Phase-2A rule:

```text
normal new Health product onboarding
=
0 product-identity-bearing production code
```

The reusable production-code changes introduced during this exercise were product-neutral governance/operational capabilities (for example source-hash location, official source observation, currentness evidence operation, batch auditing and review-routing applicability). Product identity, source lineage and temporal state remained in governed data/spec artifacts.

## What this checkpoint proves

The repository can onboard and currentness-review a multi-insurer Health batch through a common governed path while preserving:

- immutable source identity;
- explicit source/version transitions;
- separate product identity and temporal review;
- evidence-only currentness records;
- fail-closed entitlement eligibility;
- explicit historical provenance debt;
- review-routing applicability boundaries;
- zero product-identity-bearing production-code changes.

## Explicit non-claims

This checkpoint does **not** claim:

- that product facts have been automatically published;
- that current-entitlement eligibility equals publication;
- that all product semantics have been extracted or adjudicated;
- that MO-029 routing has processed product review groups in this batch;
- that review effort is already proven sub-linear with product count;
- that the full Phase-2A parent gate has passed its regression and scaling exit criteria;
- that historical product-specific modules such as `insurance_intelligence/benefits/activ_one_nxt.py` are ready for deletion.

## Remaining Phase-2A closure work

Before the parent Phase-2A gate can be certified:

1. exercise the reviewer-ready evidence-group path on real product workload so MO-029 produces measurable routing records;
2. record human-review workload/effort and demonstrate a credible path to sub-linear review scaling;
3. run the relevant Health/governance subsystem regression set and confirm zero regressions;
4. preserve material residue and unsupported semantics explicitly rather than manufacturing completeness.

Until those conditions are satisfied, `PHASE_2A_DATA_ONLY_HEALTH_ONBOARDING_AND_REVIEW_SCALING_GATE.md` remains ACTIVE.
